ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 123 filers reported holding ARRAY BIOPHARMA INC in Q1 2014. The put-call ratio across all filers is 3.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $301,608,000 | +69.9% | 6,509,988 | -10.6% | 0.02% | +57.1% |
| Q1 2019 | $177,484,000 | +71.6% | 7,279,920 | +0.3% | 0.01% | +55.6% |
| Q4 2018 | $103,408,000 | -23.9% | 7,256,734 | -18.8% | 0.01% | -10.0% |
| Q3 2018 | $135,802,000 | +5.4% | 8,934,436 | +16.3% | 0.01% | -9.1% |
| Q2 2018 | $128,888,000 | -1.0% | 7,681,261 | -3.7% | 0.01% | 0.0% |
| Q1 2018 | $130,142,000 | +9.3% | 7,974,694 | -14.3% | 0.01% | +10.0% |
| Q4 2017 | $119,100,000 | +29.9% | 9,304,834 | +24.9% | 0.01% | +25.0% |
| Q3 2017 | $91,666,000 | +14.7% | 7,452,415 | -21.9% | 0.01% | +14.3% |
| Q2 2017 | $79,890,000 | +8.1% | 9,544,525 | +15.5% | 0.01% | 0.0% |
| Q1 2017 | $73,882,000 | +30.8% | 8,264,775 | +28.6% | 0.01% | +40.0% |
| Q4 2016 | $56,498,000 | +84.2% | 6,427,728 | +41.4% | 0.01% | +66.7% |
| Q3 2016 | $30,679,000 | +141.9% | 4,544,479 | +27.5% | 0.00% | +200.0% |
| Q2 2016 | $12,683,000 | -10.7% | 3,563,329 | -26.0% | 0.00% | -50.0% |
| Q1 2016 | $14,196,000 | -30.0% | 4,812,664 | +0.1% | 0.00% | 0.0% |
| Q4 2015 | $20,294,000 | -31.1% | 4,809,038 | -25.6% | 0.00% | -33.3% |
| Q3 2015 | $29,466,000 | -27.7% | 6,461,332 | +14.3% | 0.00% | -25.0% |
| Q2 2015 | $40,757,000 | +13.5% | 5,653,077 | +16.0% | 0.00% | 0.0% |
| Q1 2015 | $35,903,000 | +56.8% | 4,871,611 | +0.6% | 0.00% | +100.0% |
| Q4 2014 | $22,899,000 | +1.3% | 4,841,504 | -23.6% | 0.00% | 0.0% |
| Q3 2014 | $22,608,000 | -5.8% | 6,333,937 | +20.4% | 0.00% | -33.3% |
| Q2 2014 | $23,988,000 | -7.5% | 5,260,401 | -4.6% | 0.00% | 0.0% |
| Q1 2014 | $25,928,000 | -31.7% | 5,516,395 | -35.1% | 0.00% | +50.0% |
| Q4 2013 | $37,949,000 | +15.3% | 8,499,126 | +60.7% | 0.00% | -50.0% |
| Q3 2013 | $32,903,000 | +78.8% | 5,289,670 | +30.5% | 0.00% | +100.0% |
| Q2 2013 | $18,405,000 | – | 4,054,339 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,459,128 | $234,543,000 | 9.43% |
| APIS CAPITAL ADVISORS, LLC | 490,000 | $6,983,000 | 9.36% |
| BVF INC/IL | 4,744,062 | $67,603,000 | 8.84% |
| First Light Asset Management, LLC | 2,853,826 | $40,667,000 | 6.48% |
| SECTORAL ASSET MANAGEMENT INC | 2,165,767 | $30,862,000 | 4.20% |
| GREAT POINT PARTNERS LLC | 1,850,000 | $26,363,000 | 3.33% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 146,952 | $2,092,000 | 2.46% |
| Birchview Capital, LP | 168,000 | $2,394,000 | 2.26% |
| X-Square Capital, LLC | 180,554 | $2,572,000 | 2.02% |
| FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD | 295,610 | $4,212,000 | 1.54% |